140
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

First green synthesis of (R)-2-methyl-1-phenylpropan-1-ol using whole-cell Lactobacillus paracasei BD101 biotransformation

Pages 138-143 | Received 03 Sep 2019, Accepted 20 Nov 2019, Published online: 06 Dec 2019

References

  • Alsafadi D, Alsalman S, Paradisi F. 2017. Extreme halophilic alcohol dehydrogenase mediated highly efficient syntheses of enantiopure aromatic alcohols. Org Biomol Chem. 15(43):9169–9175.
  • Blay G, Hernández-Olmos V, Pedro JR. 2010. Synthesis of (S)-(+)-sotalol and (R)-(−)-isoproterenol via a catalytic enantioselective Henry reaction. Tetrahedron. 21(5):578–581.
  • Brooks WH, Guida WC, Daniel KG. 2011. The significance of chirality in drug design and development. Curr Top Med Chem. 11(7):760–770.
  • Clouthier CM, Pelletier JN. 2012. Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis. Chem Soc Rev. 41(4):1585–1605.
  • Comasseto JV, Andrade LH, Omori AT, Assis LF, Porto A. 2004. Deracemization of aryl ethanols and reduction of acetophenones by whole fungal cells of Aspergillus terreus CCT 4083, A. terreus CCT 3320 and Rhizopus oryzae CCT 4964. J Mol Catal B Enzym. 29(1-6):55–61.
  • Corey EJ, Helal CJ. 1998. Reduction of carbonyl compounds with chiral oxazaborolidine catalysts: a new paradigm for enantioselective catalysis and a powerful new synthetic method. Angew Chem Int Ed. 37(15):1986–2012.
  • de Carvalho C. 2017. Whole cell biocatalysts: essential workers from nature to the industry. Microb Biotechnol. 10(2):250–263.
  • Dertli E, Mercan E, Arıcı M, Yılmaz MT, Sağdıç O. 2016. Characterisation of lactic acid bacteria from Turkish sourdough and determination of their exopolysaccharide (EPS) production characteristics. LWT-Food Sci Technol. 71:116–124.
  • Griffin DR, Yang F, Carta G, Gainer JL. 1998. Asymmetric reduction of acetophenone with calcium‐alginate‐entrapped baker’s yeast in organic solvents. Biotechnol Prog. 14(4):588–593.
  • Hall M, Stueckler C, Ehammer H, Pointner E, Oberdorfer G, Gruber K, Hauer B, Stuermer R, Kroutil W, Macheroux P, Faber K. 2008. Asymmetric bioreduction of C = C bonds using enoate reductases OPR1, OPR3 and YqjM: enzyme‐based stereocontrol. Adv Synth Catal. 350(3):411–418.
  • LaPlante SR, Fader LD, Fandrick KR, Fandrick DR, Hucke O, Kemper R, Edwards PJ. 2011. Assessing atropisomer axial chirality in drug discovery and development. J Med Chem. 54:7005–7022.
  • Lawrence NJ, Drew MD, Bushell SM. 1999. Polymethylhydrosiloxane: a versatile reducing agent for organic syntheses. J Chem Soc Perkin Trans 1. 1(1):3381–3391.
  • Lee WH, Kim MD, Jin YS, Seo JH. 2013. Engineering of NADPH regenerators in Escherichia coli for enhanced biotransformation. Appl Microbiol Biotechnol. 97(7):2761–2772.
  • Ling F, Nian S, Chen J, Luo W, Wang Z, Lv Y, Zhong W. 2018. Development of ferrocene-based diamine-phosphine-sulfonamide ligands for iridium-catalyzed asymmetric hydrogenation of ketones. J Org Chem. 83(18):10749–10761.
  • Mimoun H, de Saint Laumer JY, Giannini L, Scopelliti R, Floriani C. 1999. Enantioselective reduction of ketones by polymethylhydrosiloxane in the presence of chiral zinc catalysts. J Am Chem Soc. 121(26):6158–6166.
  • More GV, Badgujar KC, Bhanage BM. 2015. Kinetic resolution of secondary alcohols with Burkholderia cepacia lipase immobilized on a biodegradable ternary blend polymer matrix as a highly efficient and heterogeneous recyclable biocatalyst. RSC Adv. 5(6):4592–4598.
  • Noyori R, Hashiguchi S. 1997. Asymmetric transfer hydrogenation catalyzed by chiral ruthenium complexes. Acc Chem Res. 30(2):97–102.
  • Panunzio M, Rossi K, Tamanini E, Campana E, Martelli G. 2004. Synthesis of enantiomerically pure (S)-and (R)-fluoxetine (Prozac®) via a hetero Diels–Alder strategy. Tetrahedron. 15(22):3489–3493.
  • Pereira RS. 1998. The use of baker’s yeast in the generation of asymmetric centers to produce chiral drugs and other compounds. Crit Rev Biotechnol. 18(1):25–64.
  • Pollard DJ, Woodley JM. 2007. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol. 25(2):66–73.
  • Prelog V. 1964. Specification of the stereospecificity of some oxido-reductases by diamond lattice sections. Pure Appl Chem. 9(1):119–130.
  • Ranjan P, Pandey A, Binod P. 2017. Resolution of enantiopure (S)‐1‐(1‐napthyl) ethanol from racemic mixture by a novel Bacillus cereus isolate. J Basic Microbiol. 57(9):762–769.
  • Sahin E, Serencam H, Dertli E. 2019. Whole cell application of Lactobacillus paracasei BD101 to produce enantiomerically pure (S)‐cyclohexyl (phenyl) methanol. Chirality. 31:211–218.
  • Sahin E. 2018. Production of (R)-1-(1,3-benzodioxol-5-yl)ethanol in high enantiomeric purity by Lactobacillus paracasei BD101. Chirality. 30:189–194.
  • Salvi NA, Chattopadhyay S. 2016. Laboratory scale-up synthesis of chiral carbinols using Rhizopus arrhizus. Tetrahedron. 27(4-5):188–192.
  • Sato I, Saito T, Soai K. 2000. Solvent-free catalytic enantioselective addition of diethylzinc to aldehydes. Chem Commun. 24:2471–2472.
  • Sato I, Shibata T, Ohtake K, Kodaka R, Hirokawa Y, Shirai N, Soai K. 2000. Synthesis of chiral dendrimers with a hydrocarbon backbone and application to the catalytic enantioselective addition of dialkylzincs to aldehydes. Tetrahedron Lett. 41(17):3123–3126.
  • Sukhorukov AY, Sukhanova AA, Zlotin SG. 2016. Stereoselective reactions of nitro compounds in the synthesis of natural compound analogs and active pharmaceutical ingredients. Tetrahedron. 72(41):6191–6281.
  • Verho R, Londesborough J, Penttilä M, Richard P. 2003. Engineering redox cofactor regeneration for improved pentose fermentation in Saccharomyces cerevisiae. Appl Environ Microbiol. 69(10):5892–5897.
  • Winkler CK, Tasnádi G, Clay D, Hall M, Faber K. 2012. Asymmetric bioreduction of activated alkenes to industrially relevant optically active compounds. J. Biotechnol. 162(4):381–389.
  • Xiao M, Li G, Gang X, Jian PW, Li RY. 2014. A new mechanism of enantioselectivity toward chiral primary alcohol by lipase from Pseudomonas cepacia. J Mol Catal B Enzym. 109:109–115.
  • Yang GF, Huang X. 2006. Development of quantitative structure‐activity relationships and its application in rational drug design. Curr Pharm Des. 12(35):4601–4611.
  • Yılmaz D, Şahin E, Dertli E. 2017. Highly enantioselective production of chiral secondary alcohols using Lactobacillus paracasei BD 101 as a new whole cell biocatalyst and evaluation of their antimicrobial effects. Chem Biodiversity. 14(11):e1700269.
  • Yu J, Long J, Yang Y, Wu W, Xue P, Chung LW, Dong X-Q, Zhang X. 2017. Iridium-catalyzed asymmetric hydrogenation of ketones with accessible and modular ferrocene-based amino-phosphine acid (f-ampha) ligands. Org Lett. 19(3):690–693.
  • Yu S, Li H, Lu Y, Zheng G. 2018. A catalyst from Burkholderia cenocepacia for efficient anti-Prelog’s bioreduction of 3, 5-bis (trifluoromethyl) acetophenone. Appl Biochem Biotechnol. 184(4):1319–1331.
  • Zilbeyaz K, Kurbanoglu EB, Kılıç H. 2016. Preperation of enantiomerically pure (S)-(-)-1-(1-naphthyl)-ethanol by the fungus Alternaria alternate. Chirality. 28(10):669–673.
  • Zhimin O, Ma L, Niu Y, Cui J. 2018. Preparation of (R)-(-)-mandelic acid by two-step biotransformation of ethyl benzoylformate. Biocatal Biotransformation. 36(6):409–416.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.